SecBot SecBot
← Back to Analyst Consensus
IMDX Buy

Insight Molecular Diagnostics Inc.

Current Price —
Implied Upside —
Analysts 11

30-Day Momentum

▲ 0 upgrades  /  ▼ 0 downgrades  /  0 reiterations  from 0 firms

Next Earnings

Nov 5, 2026 (10 days)

Rating Timeline

Date ▼FirmActionFrom → To RatingPrice TargetFirm Rating
Aug 24, 2026LUCID CAPITAL MARKETSinitiate— → Buy—32%
Aug 18, 2026NeedhamreiterateBuy → Buy—50%
Feb 17, 2026Lake StreetmaintainBuy → Buy$1247%
Nov 11, 2025NeedhammaintainBuy → Buy$950%
Aug 18, 2025NeedhamreiterateBuy → Buy$4.2550%
May 21, 2025Lake StreetmaintainBuy → Buy$847%
May 13, 2025NeedhamreiterateBuy → Buy$4.2550%
Apr 8, 2025NeedhamreiterateBuy → Buy$4.2550%
Mar 28, 2025Lake Streetinitiate— → Buy$547%
Mar 26, 2025Stephens & Co.reiterateEqual-Weight → Equal-Weight$454%
Mar 25, 2025Stephens & Co.reiterateEqual-Weight → Equal-Weight$454%
Mar 25, 2025NeedhamreiterateBuy → Buy$4.2550%

Price Target Trend

Mar 26, 2026 Latest: $8.25 Oct 23, 2026

EPS Estimates

0q $-0.22
Lo: $-0.24 Hi: $-0.20
2 analysts
+1y $-0.80
Lo: $-0.84 Hi: $-0.76
2 analysts
0y $-0.93
Lo: $-0.93 Hi: $-0.92
2 analysts
+1q $-0.23
Lo: $-0.24 Hi: $-0.22
2 analysts

Cross-Platform Signals

No cross-platform signals in the last 90 days

Fresh Analyst Detail

Price targets, earnings estimates, and firm actions for this ticker — updated within the last 24 hours.

Subscribe for Full Access